Back to search

France· FR:64250372

EMTRICITABINE/TENOFOVIR DISOPROXIL ZENTIVA LAB 200 mg/245 mg, comprimé pelliculé

A medicinal product containing emtricitabine + fumarate de ténofovir disoproxil, registered in France by ZENTIVA FRANCE, on the national reimbursement list.

Reimbursed in France (Assurance maladie)

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedEMTRICITABINE/TENOFOVIR DISOPROXIL ZE…ATC—REGISTER NO.FR:64250372PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
EMTRICITABINE + FUMARATE DE TÉNOFOVIR DISOPROXIL
Manufacturer
ZENTIVA FRANCE
Country
France (FR)
ATC code
—
Reimbursed
Yes
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cip13
    3400930148518
    1 flacon(s) polyéthylène haute densité (PEHD) avec fermeture de sécurité enfant de 30 comprimé(s)
    EUR 151.46

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Emtricitabine + fumarate de ténofovir disoproxil in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All emtricitabine + fumarate de ténofovir disoproxil products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

  • Austria · Emtricitabin/Tenofovir Sandoz, Emtricitabin/Tenofovirdisoproxil Stada
  • Belgium · Emtricitabin/Tenofovir Disoproxil Ab
  • Cyprus · Exatron
  • Germany · Emtenovo, Emtricitabin Tenofovirdisoproxil Zentiva
  • Denmark · Emtricitabin/Tenofovirdisoproxil Tillomed, Emtricitabine/Tenofovir Disoproxil "sandoz"
  • Estonia · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Sandoz
  • Spain · Emtricitabina/Tenofovir Disoproxilo Aurovitas, Emtricitabina/Tenofovir Disoproxilo Glenmark
  • Finland · Emtricitabine / Tenofovir Disoproxil Stada, Emtricitabine/Tenofovir Disoproxil Accordpharma
  • United Kingdom (Northern Ireland) · Emtricitabin/Tenofovirdisoproxil Amarox, Emtricitabine/ Tenofovir Disoproxil
  • Greece · Argiodin, Emtricitabin/Tenofovir Disoproxil Accord
  • Croatia · Emtricitabin/Tenofovirdizoproksil Pliva
  • Hungary · Dunotrisin, Emtricitabine/Tenofovir Disoproxil Accordpharma
  • Ireland · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Clonmel
  • Iceland · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Krka
  • Italy · Emtricitabina E Tenofovir Disoproxil Aequilibrium Pharma, Emtricitabina E Tenofovir Disoproxil Aurobindo
  • Liechtenstein · Emtricitabine/Tenofovir Disoproxil Mylan, Emtricitabine/Tenofovir Disoproxil Zentiva
  • Lithuania · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Sandoz
  • Latvia · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Teva
  • Netherlands · Emtricitabine Tenofovir Disoproxyl Fumarate Aurobindo, Emtricitabine/Tenofovir Disoproxil Accordpharma
  • Norway · Emtricitabin/Tenofovirdisoproxil Tillomed, Emtricitabine/ Tenofovir Disoproxil Cipla
  • Poland · Emtricitabine + Tenofovir Disoproxil Aurovitas, Emtricitabine + Tenofovir Disoproxil Tillomed
  • Portugal · Emtricitabina + Tenofovir Accord, Emtricitabina + Tenofovir Disoproxil
  • Romania · Emtricitabină/Tenofovir Disoproxil Stada, Emtricitabină/Tenofovir Disoproxil Teva
  • Sweden · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Glenmark
  • Slovenia · Emtricitabin/Dizoproksiltenofovirat Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/abe9f4a8-1f8b-462c-a2af-77d51ac5b0d3
GET /v1/drugs/abe9f4a8-1f8b-462c-a2af-77d51ac5b0d3?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "64250372",
  "date_amm": "2018-05-30",
  "type_amm": "Procédure décentralisée",
  "numero_ue": null,
  "substance": "EMTRICITABINE + FUMARATE DE TÉNOFOVIR DISOPROXIL",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "comprimé pelliculé",
  "voies_administration": "orale",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about emtricitabine + fumarate de ténofovir disoproxil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.